Rbf Capital, LLC Enzo Biochem Inc Transaction History
Rbf Capital, LLC
- $1.61 Billion
- Q1 2025
A detailed history of Rbf Capital, LLC transactions in Enzo Biochem Inc stock. As of the latest transaction made, Rbf Capital, LLC holds 250,359 shares of ENZ stock, worth $137,697. This represents 0.01% of its overall portfolio holdings.
Number of Shares
250,359
Previous 250,359
-0.0%
Holding current value
$137,697
Previous $177,000
48.02%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ENZ
# of Institutions
31Shares Held
11.2MCall Options Held
0Put Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$2.85 Million2.17% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$814,9583.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$733,9639.62% of portfolio
-
Black Rock Inc. New York, NY955KShares$525,2620.0% of portfolio
-
Mink Brook Asset Management LLC West Palm Beach, FL808KShares$444,3440.31% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $26.8M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...